Advertisement BioElectronics signs retail distribution contract with Katz Group - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

BioElectronics signs retail distribution contract with Katz Group

BioElectronics, the maker of ActiPatch therapy, a drug free anti-inflammatory patch, has announced that Katz Group, a Canadian drugstore chain, will begin carrying the company's products by the end of January 2009 in its Rexall, Guardian, PharmaPlus and IDA drug stores.

Andrew Whelan, CEO of BioElectronics, said: “This is significant news for BioElectronics. We were already seeing strong success with London drugs in Western Canada and we have recently completed a very successful test with Zeller’s Pharmacies.

“The addition of these new chains, which give us almost Canada-wide coverage, should increase our sales levels further. We are very encouraged by our international sales growth, not only within Canada, but also within the EU.”